KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,399,591 | +85.1% | 1,044,471 | +147.3% | 0.00% | – |
Q2 2023 | $755,945 | -73.3% | 422,316 | -41.9% | 0.00% | – |
Q1 2023 | $2,826,823 | -35.5% | 726,690 | -43.6% | 0.00% | – |
Q4 2022 | $4,384,085 | -25.6% | 1,289,437 | +19.4% | 0.00% | -100.0% |
Q3 2022 | $5,896,000 | -45.2% | 1,079,881 | -54.8% | 0.00% | 0.0% |
Q2 2022 | $10,763,000 | -48.1% | 2,386,698 | -15.1% | 0.00% | -66.7% |
Q1 2022 | $20,728,000 | +202.4% | 2,812,563 | +163.9% | 0.00% | +200.0% |
Q4 2021 | $6,854,000 | -37.8% | 1,065,619 | -43.7% | 0.00% | 0.0% |
Q3 2021 | $11,017,000 | -35.0% | 1,892,933 | +15.2% | 0.00% | -50.0% |
Q2 2021 | $16,952,000 | -5.1% | 1,642,681 | -3.3% | 0.00% | -33.3% |
Q1 2021 | $17,868,000 | +55.4% | 1,698,473 | +128.6% | 0.00% | +50.0% |
Q4 2020 | $11,501,000 | +80.9% | 742,913 | +70.6% | 0.00% | +100.0% |
Q3 2020 | $6,359,000 | +87.1% | 435,578 | +142.8% | 0.00% | 0.0% |
Q2 2020 | $3,398,000 | +196.8% | 179,418 | +201.1% | 0.00% | – |
Q1 2020 | $1,145,000 | -47.2% | 59,585 | -47.3% | 0.00% | -100.0% |
Q4 2019 | $2,168,000 | +36.9% | 113,068 | -31.3% | 0.00% | – |
Q3 2019 | $1,584,000 | +129.6% | 164,636 | +42.9% | 0.00% | – |
Q2 2019 | $690,000 | -28.1% | 115,174 | -29.9% | 0.00% | – |
Q1 2019 | $960,000 | +19.4% | 164,317 | +91.4% | 0.00% | – |
Q4 2018 | $804,000 | -52.4% | 85,853 | -13.5% | 0.00% | – |
Q3 2018 | $1,689,000 | -8.2% | 99,198 | -8.4% | 0.00% | – |
Q2 2018 | $1,839,000 | -7.2% | 108,271 | -26.7% | 0.00% | -100.0% |
Q1 2018 | $1,981,000 | +195.2% | 147,612 | +111.1% | 0.00% | – |
Q4 2017 | $671,000 | -0.6% | 69,928 | +13.6% | 0.00% | – |
Q3 2017 | $675,000 | +140.2% | 61,541 | +98.3% | 0.00% | – |
Q2 2017 | $281,000 | -80.4% | 31,036 | -72.3% | 0.00% | – |
Q1 2017 | $1,436,000 | -25.5% | 111,876 | -45.5% | 0.00% | – |
Q4 2016 | $1,928,000 | +1001.7% | 205,112 | +1047.4% | 0.00% | – |
Q3 2016 | $175,000 | +400.0% | 17,877 | +246.1% | 0.00% | – |
Q2 2016 | $35,000 | -81.8% | 5,166 | -76.0% | 0.00% | – |
Q1 2016 | $192,000 | -25.3% | 21,494 | +10.9% | 0.00% | – |
Q4 2015 | $257,000 | -81.7% | 19,376 | -85.5% | 0.00% | -100.0% |
Q3 2015 | $1,405,000 | +67.9% | 133,433 | +333.9% | 0.00% | – |
Q2 2015 | $837,000 | -52.7% | 30,750 | -46.7% | 0.00% | -100.0% |
Q1 2015 | $1,768,000 | -1.2% | 57,740 | +20.8% | 0.00% | 0.0% |
Q4 2014 | $1,789,000 | +5.5% | 47,811 | -1.5% | 0.00% | 0.0% |
Q3 2014 | $1,696,000 | -19.5% | 48,537 | +7.3% | 0.00% | 0.0% |
Q2 2014 | $2,106,000 | +349.0% | 45,231 | +198.0% | 0.00% | – |
Q1 2014 | $469,000 | -82.9% | 15,180 | -87.3% | 0.00% | -100.0% |
Q4 2013 | $2,739,000 | – | 119,481 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |